Meds to control pain

Home > Flashcards > Print Preview

The flashcards below were created by user Prittyrick on FreezingBlue Flashcards. What would you like to do?

  1. Assessment of Pain
    Pain is what the person says it is. 

    • Pain is subjective and personal
    • the most reliable method is to have the patient describe his/her pain experience
    • pain rating scale
    • PQRST
    • PAIND
  2. PQRST
    P- Provacation/Palliative (what makes it worst or better)

    Quality- how would u describe it

    • R- region where is the pain does it move
    • radiating

    A- severity

    T- timing
  3. Non Pharm
    • relaxation
    • changing position
    • distraction 
    • guided imaginery
    • massaging
  4. PAIND pain rating scale for patients
    • This is for confused
    • look at vital signs
    • restlessness
    • body language
    • show pain in other way
    • bp up HR up
  5. Analgesic Ladder
    • 1st for cancer management
    • mild to severe
    • Step 1- non opiods

    Step 2- less opiods

    Step 3- greater opiods

    broken down into levels used for all pain management
  6. Analgesic ladder levels
    • Level 1- mild to moderate pain
    • - 1-3
    • - non opiods, tylenol, mortrin, adjunct as well for anxiety

    • Level 2- moderate pain
    • - 4-6
    • - weaker opiods
    • - percocets- tylenol and codiene 
    • - lesser agent with a narcotic (lesser amounts)

    • Level 3- severe pain
    • - pain >7
    • - stronger opiods
    • -demorl, morphine

    • play by ear- stop and think what is going on
    • this gives u an idea
    • u will know where to start.
  7. Opiates agonist
    Treat: moderate- severe

    Ex: demorol, Morphine, dilaudid
  8. Opiates MOA
    • Stimulates opiate receptors in the CNS
    • Mu, Kappa, and delta- work on pain to reduce pain
    • Sigma- mood and anxiety- helps with this
    • (these are opiates receptors)
    • Increases the effect of the opiate (mimic action of opiate)

    • Binds the opiat receptors and mimics the action of endogeous opiate peptides
    • - decrease the release of Substance P (pain mediator)
    • - Decreses the transmission of pain
    • - changes the perception of pain (sigma- mood)
  9. Opiates agonist other actions, CI
    • Dilation of blood vessels in the head and neck
    • suppression of the cough center (codiene suppresses cough)
    • decreases the gi/gu muscle- increase constipation

    • CI- relieves moderate to severe pain, acute and chronic pain, decrease anxiety, augment sedation and anesthesia
    • decrease cardiac workload, treat pulmonary edema and CHF
    • Because it vasodilates and reduces the amount of blood that goes back to the heart.
  10. Opiates agonist SE
    • Respitory depression- most serious (higher doses- hod if rr less than 12)
    • Orthostatic hypotension- b/c drug vasodilates
    • cough supression- u want to cough to clear secretion- respiratory secretion (pneumonia)- cough and deep breath, incentive spirometor
    • constipation
    • urinary retention
    • emesis- stimulates the CTZ
    • Euphoria/sedation- b/c it stimulates the sigma
    • miosis- constictions
    • decrease renal blood flow
  11. Opiates agonist NI
    • assess for pain
    • assess RR and BP
    • assess for precautions to use- se hold med
    • pt teaching- increase fluids, encourage coughing, 
    • drug interaction- drugs causing CNS- sedation/depression
    • assess toxicity- overdoses LOC changes
    • Antidote- Narcan
  12. Opiod Analgesics
    • MS Contin
    • - controlled release
    • - CI for chronic
    • continuous release

    • Fentanyl
    • - Transdermal system (patch)
    • - chronic pain
    • - moderate to severe pain
    • - can use with another med
    • SE- CNS sedation, respiratory depression
    • - 24 hour for full effect to occur (pt may still need to take the short term agent)
    • - patch can stay on for 72 hours (q 3 days change patch
    • -wear gloves
    • - dispose needle box (controlled area)
    • - tell pt to properly throw away seperately
  13. Prostagladins Formation
    Fever pain and inflammation

    Produced from phospholipids and are release when cell has trauma
  14. Prostagladins Production
    • Cell
    • phosopholipids get release- released, phospholipase (enzyme converts P to arachidonic acid)
    • than it converts to Arachidonic Acid- 
    • cyclooxygenase (this enzyme helps to convert into prostagladins)

    arachidonic acid- can turn into prostagladin or Thromboxone A- causes platelets to aggregate (cluster together)

    • Cox 1- found in all tissue, protects the GI mucosa, decrease acid, increases cyprotective membrane, Vasodilation, increase blood flow, helps to promote platelet aggregation (increase the risk of forming a clot), supports renal function
    • Cox 2- works on pain

    Cox- is an enzyme that needed to convert an non active substance to prostagladins
  15. Salicylates 1st generation NSAIDS
    • Non selective
    • - blocks Cox 1 &2 (cox 1 cox 2 inhibitor)
    • - Aspirin 
    • GI upset- bleeding, gi upset bc
    • when we block Cox 1 we block prostagladins. 

    • Cox 1 plays a role with Throm A- if u block cox 1 u will bleed because ur blood is not clotting
    • bc of this we get PUD and gastric ulcer
    • Works on cox 2- decrease pain

    MOA: Blocks Cox. and Throm A in the CNS and PNS

    results- decrease inflammation, pain, fever, and suppress platelet aggregation bc if blocks Throm A

  16. Salicylates NSAIDS CI
    • to reduce inflammation- decrease prosta.
    • mild to moderate pain- de prosta
    • decrease fever- blocks Cox 2 de prosta
    • suppresion of platelet aggregation (TIA ischemia attack, CVA, MI)- blocks Throm A (low dose aspirin helps to keep platelets from clustering and blood flows easily)

    • SE: GI (block COX 1 loss protetive function), bleeding, renal insufficiency, 
    • salicylism- overdose/toxicity 1st s/s tinnitus (reversible)
    • Reyes Syndrome- we dont see much, viral infection- tends to be in children and it caused brain damage. we dont see this often because we don't give to children anymore
  17. Salicylates NSAIDS NI
    • Accurate pain assessment
    • assess allergy 
    • Drug interaction- OTC becareful of other drugs that can cause bleeding
    • 1 week prior to surgery tell pt to stop aspirin bc bleeding
    • take with food to decrease GI upset.
  18. NSAIDS (non steriodal inflammatory drug)
    Non Selective Inhibitors
    Ex: Motrin (ibuprofen), Naxproxen

    • MOA: The inhibit prostagladins synthesis
    • Differetn NSAIDS disrupt the synthesis at different stages
    CI: antiflammatory, analgesic (mild to moderate pain, antipyretic

    SE: GI upset, increase risk for PUD, GI bleed, renal insufficiency, hypersensitivity 

    • NI: accurate pain assessment
    • increased risk of SE with elderly
    • drug interaction- other drugs that can increase bleeding
    • GI upset take with meals
  20. NSAIDS (naproxen, toradol (ketoroiac Tromethamine))
    • naproxen- pain related to joint disease (ortho)
    • high risk GI upset- nausea, PUD (u can take a PPI, H2), multiple drug interactions

    • Toradol (ketoroiac tromethamine)
    • short term pain relief (post op)
    • administer IV, IM
    • equal to demorol with fewer SE
    • SE: GI
    • Administer no more than 5 days after 5 days increase the risk of renal disease. 
    • starts to work with in ten minutes
  21. Cyclooxgenase 2 inhibitors
    selective inhibitor
    they keep the protective GI, and does not aggregate the platelets

    • Selective anti-inflammatory
    • reduce pain, inflammation, keep protective membrane
    • less GI bleeding and SE

    Ex: Celebrex

    MOA: inhibits Cox 2 enzyme blocker, decrease prostagladin synthesis

    • CI: mild, moderate pain, anti inflammatory
    • leep proctective effect in the GI
    • no platelet aggregation
  22. Cox 2 inhibitor Cerebrex SE, NI
    • SE: less GI upset and bleeding s/e than NSAIDS
    • headache, dizziness

    • NI: accurate pain assessment
    • allergy to Sulfa or aspirin bc it will increase the risk hypersensitivity
    • admin with food
    • drug interaction
    • more expensive
  23. Para Aminophenol Derivatives
    ex: acetaminophin (tylenol)

    MOA: selective prostaglandins inhibition in the CNS

    CI: analgesia (mild-moderate pain), antipyretic
  24. Para Aminophenol Derivatives SE NI
    • SE: rare at therapeutic- large dosage can cause liver damage
    • Usually less than 4g in 24 hours

    • NI: accurate assessment of pain
    • pain teaching
    • antidote: mucomyst (tylenol toxicity) helps to prevent liver damage (helps with not metabolizing the drug in the liver)
    • becareful of other agents that have tylenol
  25. Adjunct pain relief
    • neurontin- (Gabapentin)
    • use of chronic pain, neuropathic pain
    • MOA: not fully understood
    • SE: CNS
    • PTSD, Bipolar
    • well tolerated

    Tricyclic antidepressants, anticonvulsants- neuropathic pain- help decrease nerve transmission

    Glucocorticoids- decrease inflammation, decrease intracranial and intraspinal pressure- decrease pain
  26. Drugs affecting muscle spasms and spasticity
    • Muscle spasm: sudden involuntary contraction of a muscle or group of muscles
    • - work varies points either on the muscle or the CNS to decrease pain and spasm
    • - acute trauma, skeletal muscle imjury, electrolyte imbalance
    • - treated with centrally acting muscle relaxants, anti inflammatory agents, PT

    • Spasticity certain muscles are continously contracted
    • - damaged to the brain, SC
    • - treated with Spasmolytics
  27. Centrally Acting Muscle Relaxants
    Ex: Flexeril (cyclobenzapine)

    MOA: centrally acting- works in the CNS causes CNS depression, decreases nerve transmission at the spinal cord

    SE: CNS

    • NI: accurate assessment
    • assess safety
    • assess for CNS depression
    • drug interaction with other CNS depression
    • optimal effects in 1-2 weeks (not immediate)
    • short term- do not use longer than 3-4 weeks
  28. Centrally Acting muscle relaxants

    ex: Baclofen 

    • MOA: precise mechanism is unknown
    • works on GABA increase at the motor neurons to decrease impulses

    • CI: Skeletal muscle relaxant, muscle spasms, spinal spasticity 
    • Drug of choice for spasticity
    • baclofen pump- pt with spinal cord injury. inserted pump under the skin
  29. Centrall acting muscle relaxants SE NI
    • Se: CNS- drowiness, headache dizziness
    • other- gi, myalgias, tremors, ataxia, visual disturbances, hyperglycemia

    • NI: accurate assessment
    • titrate dose to control SE
    • assess safety needs
    • can increase the risk of seizures- reduced the seizure threshold
    • abrupt withdrawl: hallucinations, seizures, drug interactions CNS
  30. Direct acting Muscle relaxants
    Ex: dantrolene (dantrium)

    MOA: direct affect on skeletal muscle fibers. it interfers with the amount of ca released from the sacroplasmic reticulum

    CI; relief of muscle spasms, spasticity
  31. Directing acting muscle relaxants SE NI
    • SE: most common is muscle weakness
    • other Gi upset
    • drowiness, dizziness (low) bc doesnt work on CNS 
    • hepatoxicity

    • NI:
    • accurate assessment
    • low doses and titrate up to reduce se
    • safety concerns- risk for falls
    • drug interaction 
    • drug effects usually seen 1-2 weeks
    • administer with food to decrease gi upset

Card Set Information

Meds to control pain
2014-06-14 01:25:09

Fun pain no gain
Show Answers:

What would you like to do?

Home > Flashcards > Print Preview